Memantine in Adult Autism Spectrum Disorder.
Phase of Trial: Phase II
Latest Information Update: 29 Jul 2017
At a glance
- Drugs Memantine (Primary)
- Indications Asperger syndrome; Autistic disorder; Pervasive child development disorders
- Focus Therapeutic Use
- 27 Jul 2017 Status changed from recruiting to discontinued.
- 07 Mar 2010 New trial record